Form 4: IQVIA Executive W. Richard Staub Reports Stock Transactions Following Performance Milestone
SEC Form 4 Filing
W. Richard Staub, President of Research & Development Solutions at IQVIA, acquired shares and stock appreciation rights following the achievement of performance criteria, while also disposing of shares to cover tax obligations.
Summary
- W. Richard Staub, an executive at IQVIA Holdings Inc., reported transactions involving the company's stock on January 28, 2025.
- He acquired 1,571 shares of common stock as a result of performance-based restricted stock units that vested after the company's Leadership Development and Compensation Committee determined the performance conditions were met.
- Additionally, he acquired 24,580 stock appreciation rights (SARs) that vest in three annual installments starting January 28, 2026.
- To cover tax obligations, Mr. Staub disposed of 479 shares of common stock at a price of $203.43 per share.
- Following these transactions, Mr. Staub directly owns 17,037 shares of common stock and 24,580 stock appreciation rights.
Sentiment
Score: 7
Explanation: The document reflects a positive event (vesting of performance-based compensation) and routine tax-related stock disposal. The sentiment is moderately positive as it indicates the company met performance targets.
Positives
- The vesting of performance-based restricted stock units indicates that the company met certain performance criteria.
- The acquisition of stock appreciation rights suggests a positive outlook for the company's future performance.
Negatives
- The disposal of 479 shares, while for tax purposes, could be interpreted as a slight reduction in the executive's direct stake.
Risks
- The value of the stock appreciation rights is dependent on the future performance of the company's stock price.
- Changes in tax laws could impact the financial implications of these transactions.
Future Outlook
The stock appreciation rights vest in three annual installments beginning on January 28, 2026, indicating a long-term incentive for the executive.
Management Comments
- The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on January 28, 2025.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It reflects the company's compensation structure and performance-based incentives.
Comparison to Industry Standards
- Stock-based compensation, including restricted stock units and stock appreciation rights, is a common practice among publicly traded companies, particularly in the technology and healthcare sectors, such as IQVIA.
- The vesting schedules and performance criteria are generally aligned with industry standards for executive compensation.
- Companies like Oracle, Accenture, and Cognizant also use similar stock-based compensation plans to incentivize their executives.
Stakeholder Impact
- Shareholders may view the vesting of performance-based compensation as a positive sign of the company's performance.
- Employees may see this as a positive indicator of the company's commitment to rewarding performance.
Next Steps
- The stock appreciation rights will vest in three annual installments starting January 28, 2026.
Key Dates
| Date | Description |
|---|---|
| 02/10/2022 | Date of grant of performance-based restricted stock units. |
| 01/28/2025 | Date of transaction, vesting of restricted stock units, and grant of stock appreciation rights. |
| 01/28/2026 | Start date for the vesting of stock appreciation rights in three annual installments. |
| 01/28/2035 | Expiration date of the stock appreciation rights. |
| 01/30/2025 | Date of signature of the Form 4 filing. |
Keywords
IQVIA, stock appreciation rights, restricted stock units, executive compensation, insider trading, Form 4, W. Richard Staub, performance-based vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.